Brief: Cocrystal Pharma Announces Up To $13 Mln Direct Offering Priced At-Market Under Nasdaq Rules
12/09/2025 15:35
Sept 12 (Reuters) - Cocrystal Pharma Inc COCP.O: COCRYSTAL PHARMA, INC. ANNOUNCES UP TO $13 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES COCRYSTAL PHARMA, INC. ANNOUNCES UP TO $13 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES Source text: ID:nGNX6xN0sJ Further company coverage: COCP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cocrystal Pharma
See all newsBrief: Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Human Challenge Study Evaluating CDI-988 For Norovirus Prevention And Treatment
Cocrystal Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Cocrystal Pharma Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway